| 0.1 |
0.4 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.1 |
0.8 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.1 |
0.3 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.1 |
0.8 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.1 |
0.3 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.1 |
0.6 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.1 |
0.3 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.1 |
0.3 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.1 |
0.3 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.1 |
0.3 |
GO:0034499 |
late endosome to Golgi transport(GO:0034499) |
| 0.1 |
0.2 |
GO:0099541 |
retrograde trans-synaptic signaling(GO:0098917) trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) |
| 0.1 |
0.2 |
GO:0090340 |
positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of pancreatic juice secretion(GO:0090187) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 0.1 |
0.2 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.1 |
0.2 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.0 |
0.5 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.0 |
0.1 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 |
0.1 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.0 |
0.3 |
GO:0019918 |
peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.0 |
0.1 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.0 |
0.2 |
GO:0098502 |
DNA dephosphorylation(GO:0098502) |
| 0.0 |
0.2 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.0 |
0.1 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.0 |
0.2 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.0 |
0.1 |
GO:0038108 |
negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.0 |
0.2 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.0 |
0.2 |
GO:2000313 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.0 |
0.3 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 |
0.1 |
GO:1904448 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) negative regulation of dopamine secretion(GO:0033602) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.0 |
0.1 |
GO:0060298 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) positive regulation of sarcomere organization(GO:0060298) |
| 0.0 |
0.1 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.0 |
0.1 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.0 |
0.2 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.0 |
0.0 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.0 |
0.2 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) protein O-linked glycosylation via serine(GO:0018242) |
| 0.0 |
0.6 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.0 |
0.4 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.0 |
0.4 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.0 |
0.2 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.0 |
0.1 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.0 |
0.6 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.0 |
0.4 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.0 |
0.1 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.0 |
0.1 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 |
0.3 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.0 |
0.2 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.0 |
1.0 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.1 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.0 |
0.1 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.0 |
0.1 |
GO:0097360 |
chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.0 |
0.1 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
| 0.0 |
0.6 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.1 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.0 |
0.1 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.0 |
0.1 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.0 |
0.2 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.0 |
0.1 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.0 |
0.1 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 |
0.1 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.0 |
0.3 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.0 |
0.3 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 |
0.2 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.0 |
0.0 |
GO:2000625 |
regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
| 0.0 |
0.4 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.0 |
0.1 |
GO:1903912 |
negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.0 |
0.2 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
0.1 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 |
0.1 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.0 |
0.2 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.0 |
0.2 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.0 |
0.1 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.0 |
0.0 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.0 |
0.0 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.0 |
0.0 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.0 |
0.2 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.0 |
0.1 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.0 |
0.2 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.0 |
0.0 |
GO:0002514 |
B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
| 0.0 |
0.0 |
GO:0061009 |
common bile duct development(GO:0061009) |
| 0.0 |
0.0 |
GO:0006174 |
dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
| 0.0 |
0.2 |
GO:0048665 |
neuron fate specification(GO:0048665) |
| 0.0 |
0.2 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
